02/10/2022 Le Temps writes about Genknowme 26/09/2022 Genknowme is part of the 10 startups selected by Future of Health Grant program 08/04/2022 Genknowme launches a new digital platform 05/04/2022 Biopole’s entrepreneur share: Semira Gonseth Nusslé, Co-founder and CMO at Genknowme 17/03/2022 Genknowme’s Biological Age Patent is filed 09/09/2021 Biopôle Start-up Fund: Novostia and Genknowme are the first start-ups nominated 26/05/2021 Genknowme’s company portrait by INNOVAUD 18/03/2021 Clinique La Prairie, a leader in anti-aging medicine, chooses Genknowme for its epigenetic tests 19/01/2021 Unisanté and Genknowme join forces to explore the impacts of lifestyle on epigenetics 19/11/2020 A first partnership with the Swiss Center for Preventive Medicine for the epigenetic profile of Genknowme 24/09/2020 How seven innovative Swiss companies question the status quo – and thus make our everyday lives easier and more livable. 12/05/2020 Genknowme has obtained a Tech Seed loan of CHF 100’000 from the Foundation for Technological Innovation (FIT). 23/03/2020 Genknowme won the VentureKick competition and is granted a CHF 150’000 loan to kick up our startup! 06/03/2020 Genknowme’s CEO is interviewed in l’AGEFI 23/10/2019 Genknowme is accepted in the startup accelerator of Groupe Mutuel, Innopeaks. 05/09/2019 Genknowme won CHF 40’000 in the stage 2 of the VentureKick competition!
18/03/2021 Clinique La Prairie, a leader in anti-aging medicine, chooses Genknowme for its epigenetic tests
19/11/2020 A first partnership with the Swiss Center for Preventive Medicine for the epigenetic profile of Genknowme
24/09/2020 How seven innovative Swiss companies question the status quo – and thus make our everyday lives easier and more livable.
12/05/2020 Genknowme has obtained a Tech Seed loan of CHF 100’000 from the Foundation for Technological Innovation (FIT).
23/03/2020 Genknowme won the VentureKick competition and is granted a CHF 150’000 loan to kick up our startup!
